Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease
Clinical trial NCT03818685 · UNKNOWN
Trial details
- NCT number
- NCT03818685
- Sponsor
- Centre Leon Berard
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-02
- Primary completion
- 2024-03-15
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.